...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >ANKRD26-related thrombocytopenia and myeloid malignancies.
【24h】

ANKRD26-related thrombocytopenia and myeloid malignancies.

机译:ANKRD26相关的血小板减少症和骨髓恶性肿瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

Since the discovery that mutations in the 5' untranslated region (UTR) of ANKRD26 are responsible for an autosomal-dominant form of thrombocytopenia (ANKRD26-RT), 21 affected families were reported.2 A study analyzing this series of patients suggested that ANKRD26-KT is characterized by normal platelet size, moderate thrombocytopenia, and absent or mild bleeding tendency. The study also found that the number of hematologic malignancies in affected families was higher than expected, but the relatively small cohort of patients precluded firm conclusions.To gain further information on this matter, we screened for mutations in the 5' UTR of ANKRD26 215 subjects with an inherited thrombocytopenia of unknown origin and found 11 mutations (3 not previously described) in 23 cases (Table I).
机译:由于发现ANKRD26的5'未转换区域(UTR)中的突变对血小板减少(ANKRD26-RT)的常规显性形式(ANKRD26-RT)负责,因此报告了21个受影响的家族.2分析这一系列患者的研究表明ANKRD26- Kt以正常的血小板尺寸,适度的血小板减少症和缺乏或轻度渗出倾向为特征。 该研究还发现受影响家庭的血液学恶性肿瘤数量高于预期,但相对较小的患者队列排除了坚定的结论。获取有关此事的进一步信息,我们筛选了ANKRD26 215主题的5'UTR中的突变。 在23例中,遗传血小阴蛋白未知来源的血小阴十尼,并发现11例突变(3例未描述)(表I)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号